SYM FINANCIAL Corp Makes New Investment in Molina Healthcare, Inc. (NYSE:MOH)

SYM FINANCIAL Corp bought a new stake in shares of Molina Healthcare, Inc. (NYSE:MOH) in the 4th quarter, HoldingsChannel reports. The fund bought 856 shares of the company’s stock, valued at approximately $249,000.

A number of other hedge funds also recently made changes to their positions in MOH. NFJ Investment Group LLC purchased a new stake in Molina Healthcare during the third quarter worth about $7,432,000. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH boosted its stake in Molina Healthcare by 406.6% in the third quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 21,996 shares of the company’s stock valued at $7,579,000 after acquiring an additional 17,654 shares during the last quarter. KBC Group NV grew its position in shares of Molina Healthcare by 14.6% during the 4th quarter. KBC Group NV now owns 125,486 shares of the company’s stock valued at $36,522,000 after acquiring an additional 15,993 shares during the period. Raymond James & Associates increased its stake in shares of Molina Healthcare by 59.9% during the 3rd quarter. Raymond James & Associates now owns 42,298 shares of the company’s stock worth $14,574,000 after purchasing an additional 15,840 shares during the last quarter. Finally, Integrated Investment Consultants LLC bought a new stake in shares of Molina Healthcare in the 3rd quarter worth approximately $4,716,000. 98.50% of the stock is currently owned by institutional investors.

Molina Healthcare Stock Performance

NYSE MOH opened at $310.10 on Monday. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.54 and a quick ratio of 1.55. The company’s 50 day simple moving average is $297.44 and its two-hundred day simple moving average is $317.93. The stock has a market capitalization of $17.74 billion, a PE ratio of 15.75, a P/E/G ratio of 0.94 and a beta of 0.54. Molina Healthcare, Inc. has a 1 year low of $272.69 and a 1 year high of $423.92.

Analyst Upgrades and Downgrades

MOH has been the subject of a number of recent research reports. Wells Fargo & Company raised their target price on Molina Healthcare from $360.00 to $362.00 and gave the stock an “equal weight” rating in a research report on Monday, November 4th. Barclays lifted their price objective on Molina Healthcare from $359.00 to $372.00 and gave the stock an “equal weight” rating in a report on Friday, October 25th. Robert W. Baird dropped their price objective on shares of Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. StockNews.com upgraded shares of Molina Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Friday. Finally, Truist Financial lowered their price target on shares of Molina Healthcare from $400.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, four have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Molina Healthcare has a consensus rating of “Moderate Buy” and an average target price of $359.18.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.